Frontiers in Medicine (Dec 2019)

The First Case of Ischemia-Free Kidney Transplantation in Humans

  • Xiaoshun He,
  • Xiaoshun He,
  • Xiaoshun He,
  • Guodong Chen,
  • Guodong Chen,
  • Guodong Chen,
  • Zebin Zhu,
  • Zebin Zhu,
  • Zebin Zhu,
  • Zhiheng Zhang,
  • Zhiheng Zhang,
  • Zhiheng Zhang,
  • Xiaopeng Yuan,
  • Xiaopeng Yuan,
  • Xiaopeng Yuan,
  • Ming Han,
  • Ming Han,
  • Ming Han,
  • Qiang Zhao,
  • Qiang Zhao,
  • Qiang Zhao,
  • Yitao Zheng,
  • Yitao Zheng,
  • Yitao Zheng,
  • Yunhua Tang,
  • Yunhua Tang,
  • Yunhua Tang,
  • Shanzhou Huang,
  • Shanzhou Huang,
  • Shanzhou Huang,
  • Linhe Wang,
  • Linhe Wang,
  • Linhe Wang,
  • Otto B. van Leeuwen,
  • Xiaoping Wang,
  • Xiaoping Wang,
  • Xiaoping Wang,
  • Chuanbao Chen,
  • Chuanbao Chen,
  • Chuanbao Chen,
  • Liqiu Mo,
  • Xingyuan Jiao,
  • Xingyuan Jiao,
  • Xingyuan Jiao,
  • Xianchang Li,
  • Xianchang Li,
  • Xianchang Li,
  • Xianchang Li,
  • Changxi Wang,
  • Changxi Wang,
  • Changxi Wang,
  • Jiefu Huang,
  • Jiefu Huang,
  • Jun Cui,
  • Zhiyong Guo,
  • Zhiyong Guo,
  • Zhiyong Guo

DOI
https://doi.org/10.3389/fmed.2019.00276
Journal volume & issue
Vol. 6

Abstract

Read online

Background: Ischemia-reperfusion injury (IRI) has been considered an inevitable event in organ transplantation since the first successful kidney transplant was performed in 1954. To avoid IRI, we have established a novel procedure called ischemia-free organ transplantation. Here, we describe the first case of ischemia-free kidney transplantation (IFKT).Materials and Methods: The kidney graft was donated by a 19-year-old brain-dead donor. The recipient was a 47-year-old man with end-stage diabetic nephropathy. The graft was procured, preserved, and implanted without cessation of blood supply using normothermic machine perfusion.Results: The graft appearance, perfusion flow, and urine production suggested that the kidney was functioning well-during the whole procedure. The creatinine dropped rapidly to normal range within 3 days post-transplantation. The levels of serum renal injury markers were low post-transplantation. No rejection or vascular or infectious complications occurred. The patient had an uneventful recovery.Conclusion: This paper marks the first case of IFKT in humans. This innovation may offer a unique solution to optimizing transplant outcomes in kidney transplantation.

Keywords